| Tag | Content |
|---|
EnhancerAtlas ID | HS037-00178 |
Organism | Homo sapiens |
Tissue/cell | ESC |
Coordinate | chr1:9848870-9849820 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFAT5 | MA0606.1 | chr1:9849343-9849353 | ATTTTCCATT | + | 6.02 | | NFATC1 | MA0624.1 | chr1:9849343-9849353 | ATTTTCCATT | + | 6.02 | | NFATC3 | MA0625.1 | chr1:9849343-9849353 | ATTTTCCATT | + | 6.02 | | ZIC1 | MA0696.1 | chr1:9849042-9849056 | GCCCCCCTGCTGTG | + | 6.87 | | ZIC3 | MA0697.1 | chr1:9849042-9849057 | GCCCCCCTGCTGTGG | + | 6.03 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_58597 | chr1:9839934-9924553 | Ly1 | | SE_60860 | chr1:9844192-9884805 | DHL6 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | AGCCAAGATC ACGCCACTGC ACTCCAAGCT GGGCGACAGA GCGAGACTCC GTCTCAAAAA 60
AAAAAAAAAA AAAAAACAAA AGGAATTTGA CTATTCTAGT ACCTCATATG AGTGGGATCA 120
CACCACACTT ATCCTTTTGT AACTGGCTTC ATTAGCATAA TGTCCTCGAG GTGCCCCCCT 180
GCTGTGGCAT GCGTTGGAAT TCCTTTTCGA GGCTGGATGA TGTTCCGTTA GAAGGATACC 240
ATGTTTTGCT TATCCATTCC CTGGTTAACA GACGCTGGGT TGCTTCCACC TTTTGGCCAT 300
TGTGAACAAT GCTGCTAATG CTGGTGTACA AATACCTCAA GGCCCTGTTT TCTAATCTTT 360
TGTGAATATG CCCAGAAGGC GGACTGCTGG ATCATACGGT GATTCTATCT TTAGGGTGAT 420
TGTATCTTTG TGTTTTGAGG AGCCGCCATA CCGTTCTCCA TAGTGACTGC ACCATTTTCC 480
ATTCCCACCA ACCGTGCACA AGGGCCCCGA TTTCTCCACC TCCTTCCCAG CACTTGTTAT 540
TTTCTGCTTT TTGATAGACC ATCCTAACAG ATGAAACCAA ACATGCTTTA TATCAAGTAA 600
TTTTACCTTC TCGTATTGTG TAAAATTGAT AAGATACCAA AGTAGACAAC AGAGAGTAAG 660
AAGCCCCATG TGCTCCTCAC TAACCACTAT AATGATCCAC GCAGAATGAA TCTTGTTTGA 720
CTTCACTCCC ACTCCCAACA CCGATACCAC TTATTTTGAA GCAAATGCCA GACATCATAT 780
AACTTCCCCT CTCAATACCG CATCATACAT CTCTAAAAGA TAACAACTCT TTTTAAAACT 840
AACCATATCA AGTCCAATAG AGCTTAAAGG TAAAAAATAA AATAAGCTGG GAGAGGTGGC 900
TTATGCCTGT AATCCCAGCA CTTTGGGAGG CTAAGGAGAG TGGATTGCTT 950
|
